{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:16:41Z","timestamp":1790720201110,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-061093"],"award-info":[{"award-number":["AI-061093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-086037"],"award-info":[{"award-number":["AI-086037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-48693"],"award-info":[{"award-number":["AI-48693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.humimm.2018.10.015","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T11:56:00Z","timestamp":1540209360000},"page":"351-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Primary B-cell immunodeficiencies"],"prefix":"10.1016","volume":"80","author":[{"given":"Tukisa","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2018.10.015_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2011.06338.x","article-title":"Perspectives on common variable immune deficiency","volume":"1246","author":"Park","year":"2011","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.humimm.2018.10.015_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0167-5699(93)90322-C","article-title":"The turnover of B-cell populations","volume":"14","author":"Osmond","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1016\/j.humimm.2018.10.015_b0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0020","series-title":"Stiehm\u2019s Immune Deficiencies","article-title":"Chapter 13 \u2013 agammaglobulinemia","author":"Plebani","year":"2014"},{"key":"10.1016\/j.humimm.2018.10.015_b0025","doi-asserted-by":"crossref","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.humimm.2018.10.015_b0030","first-page":"200","article-title":"Agammaglobulinemiae","volume":"66","author":"Gitlin","year":"1953","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.humimm.2018.10.015_b0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0031-3955(16)30945-2","article-title":"Clinical investigation of patients with agammaglobulinemia and hypogammaglobulinemia","volume":"7","author":"Good","year":"1960","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.humimm.2018.10.015_b0040","first-page":"610","article-title":"Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway","volume":"96","author":"Nomura","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2018.10.015_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a membe","volume":"361","author":"David","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2018.10.015_b0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.152.2.557","article-title":"Expression of Bruton\u2019s agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells","volume":"152","author":"Smith","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.humimm.2018.10.015_b0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B-cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2018.10.015_b0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0090-1229(77)90070-8","article-title":"Hypoimmunoglobulinemia with normal T cell function in female siblings","volume":"7","author":"Good","year":"1977","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.humimm.2018.10.015_b0075","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJM199611143352003","article-title":"Mutations in the Mu heavy-chain gene in patients with agammaglobulinemia","volume":"335","author":"Yel","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI0215658","article-title":"Clinical and molecular analysis of patients with defects in \u03bc heavy chain gene","volume":"110","author":"Lopez Granados","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.10.015_b0085","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts","author":"Conley","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/0167-5699(93)90060-X","article-title":"The surrogate light chain in B-cell development","author":"Melchers","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1016\/j.humimm.2018.10.015_b0095","unstructured":"E4511D2F-7699-4FCA-94D1-F2F5463A6ADA, (n.d.)."},{"key":"10.1016\/j.humimm.2018.10.015_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/science.7716544","article-title":"The role of Ig beta in precursor B cell transition and allelic exclusion","volume":"268","author":"Papavasiliou","year":"1995","journal-title":"Science (80\u2013)"},{"key":"10.1016\/j.humimm.2018.10.015_b0105","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.iy.10.040192.000525","article-title":"Antigen receptors on B lymphocytes","author":"Reth","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.10296","article-title":"Novel Ig\u03b1 (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia","volume":"108","author":"Wang","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.humimm.2018.10.015_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/science.286.5446.1954","article-title":"An essential role for BLNK in human B cell development","volume":"286","author":"Minegishi","year":"1999","journal-title":"Science (80-)"},{"key":"10.1016\/j.humimm.2018.10.015_b0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.20112533","article-title":"Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K","volume":"209","author":"Conley","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/ni1260","article-title":"Helix-loop-helix proteins and lymphocyte development","author":"Murre","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0130","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1172\/JCI71927","article-title":"A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(\u2212) B cells","volume":"123","author":"Boisson","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.10.015_b0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1586\/eci.09.43","article-title":"Role of B cells in common variable immune deficiency","volume":"5","author":"Ahn","year":"2009","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0140","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM195406172502403","article-title":"Absence of serum gamma globulins in an adult","volume":"250","author":"Sanford","year":"1954","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0145","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27+IgM\u2212IgD\u2212) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10875-014-0053-0","article-title":"Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets \u2013 a review of the current knowledge","volume":"34","author":"Varzaneh","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0155","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-04-1325","article-title":"Common variable immunodeficiency is associated with defective functions of dendritic cells","volume":"104","author":"Bayry","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2009.05.019","article-title":"Toll-like receptor 7 and 9 defects in common variable immunodeficiency","volume":"124","author":"Yu","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0165","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2015.09.013","article-title":"Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency","volume":"137","author":"Cols","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0170","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0175","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0180","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2014.04.024","article-title":"Pulmonary radiologic findings in CVID: clinical and immunological correlations","volume":"113","author":"Maglione","year":"2014","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0185","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10875-011-9565-z","article-title":"Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events","volume":"31","author":"da Silva","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0190","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0195","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.humimm.2018.10.015_b0200","doi-asserted-by":"crossref","unstructured":"Q. Pan-Hammarstr\u00f6m, U. Salzer, L. Du, J. Bj\u00f6rkander, C. Cunningham-Rundles, D.L. Nelson, C. Bacchelli, B. Gaspar, S. Offer, T.W. Behrens, B. Grimbacher, L. Hammarstr\u00f6m, Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency (n.d.). Doi: 10.1038\/ng0407-429.","DOI":"10.1038\/ng0407-429"},{"key":"10.1016\/j.humimm.2018.10.015_b0205","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI31023","article-title":"Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)","volume":"117","author":"Garibyan","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.10.015_b0210","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jaci.2015.05.012","article-title":"TNFRSF13B hemizygosity reveals TACI haploinsufficiency at later stages of B-cell development","volume":"136","author":"Romberg","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0215","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2012.10.029","article-title":"TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes","volume":"131","author":"Martinez-Gallo","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0220","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0225","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1172\/JCI74428","article-title":"TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen","volume":"124","author":"Tsuji","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.10.015_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/nri3466","article-title":"Primary antibody deficiencies","author":"Durandy","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0235","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2018.10.015_b0240","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","article-title":"Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency","volume":"25","author":"Losi","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0245","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1073\/pnas.1221211110","article-title":"Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2018.10.015_b0250","doi-asserted-by":"crossref","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","author":"Grimbacher","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/16717","article-title":"ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28","volume":"397","author":"Hutloff","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2018.10.015_b0260","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood-2005-07-2955","article-title":"Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency","volume":"107","author":"Warnatz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0265","doi-asserted-by":"crossref","unstructured":"M.C. Van Zelm, I. Reisli, M. Van Der Burg, D. Casta\u00f1o, C.J.M. Van Noesel, J.D. Van Tol, C. Woellner, B. Grimbacher, P.J. Pati\u00f1o, J.J.M. Van Dongen, J.L. Franco, An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene Abstract, 2006, www.nejm.org.","DOI":"10.1056\/NEJMoa051568"},{"key":"10.1016\/j.humimm.2018.10.015_b0270","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"van Zelm","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.10.015_b0275","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2011.09.027","article-title":"Genetic CD21 deficiency is associated with hypogammaglobulinemia","volume":"129","author":"Thiel","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0280","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI40231","article-title":"CD20 deficiency in humans results in impaired T cell\u2013independent antibody responses","volume":"120","author":"Kuijpers","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.10.015_b0285","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaci.2011.11.013","article-title":"CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia","volume":"129","author":"van Montfrans","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0290","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.humimm.2018.10.015_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.05.043","article-title":"LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency","volume":"130","author":"Alangari","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0300","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0305","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by Cd25(+)Cd4(+)regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4","volume":"192","author":"Takahashi","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0310","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science (80\u2013)"},{"key":"10.1016\/j.humimm.2018.10.015_b0315","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.humimm.2018.10.015_b0320","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K","volume":"211","author":"Lucas","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0325","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1gene","volume":"124","author":"Deau","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.10.015_b0330","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0335","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0340","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2014.02.020","article-title":"Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-Kinase \u03b4 syndrome","volume":"134","author":"Kracker","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0345","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","article-title":"Germline mutations in NFKB2 implicate the noncanonical NF-\u03baB pathway in the pathogenesis of common variable immunodeficiency","volume":"93","author":"Chen","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.humimm.2018.10.015_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans","author":"Tuijnenburg","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0355","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/ar3904","article-title":"Immunoglobulin class-switch recombination deficiencies","volume":"14","author":"Durandy","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.humimm.2018.10.015_b0360","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0065-2776(06)94009-7","article-title":"Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies","volume":"94","author":"Durandy","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0365","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","article-title":"The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome","volume":"72","author":"Aruffo","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2018.10.015_b0370","doi-asserted-by":"crossref","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.humimm.2018.10.015_b0375","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.2.977","article-title":"Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM","volume":"158","author":"Hayward","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0380","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2169\/internalmedicine.45.6023","article-title":"Progressive multifocal leukoencephalopathy complicating X-linked hyper-IgM syndrome in an adult","volume":"45","author":"Suzuki","year":"2006","journal-title":"Intern. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.humimm.2018.10.015_b0390","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","article-title":"Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features","volume":"203","author":"Lougaris","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2018.10.015_b0395","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","article-title":"Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2)","volume":"102","author":"Revy","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2018.10.015_b0400","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/humu.20414","article-title":"Activation-induced cytidine deaminase: structure\u2013function relationship as based on the study of mutants","volume":"27","author":"Durandy","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.humimm.2018.10.015_b0405","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/clim.2000.4956","article-title":"Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome","volume":"97","author":"Minegishi","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0410","doi-asserted-by":"crossref","DOI":"10.1097\/01.bor.0000231905.12172.b5","article-title":"Hyper-IgM syndromes","volume":"18","author":"Durandy","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.humimm.2018.10.015_b0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","article-title":"Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency","volume":"110","author":"Quartier","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0420","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1084\/jem.20050042","article-title":"B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil","volume":"201","author":"Kavli","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0425","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni974","article-title":"Human uracil\u2013DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination","volume":"4","author":"Imai","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0430","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10875-009-9357-x","article-title":"Selective IgA deficiency","volume":"30","author":"Yel","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0435","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0440","series-title":"Prim. Immunodefic. Dis. Defin. Diagnosis, Manag.","first-page":"97","article-title":"Predominantly antibody deficiencies","author":"Aghamohmmadi","year":"2008"},{"key":"10.1016\/j.humimm.2018.10.015_b0445","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1012241117984","article-title":"Physiology of IgA and IgA deficiency","volume":"21","author":"Cunningham-Rundles","year":"2001","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0450","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2009.05.014","article-title":"Selective IgA deficiency in early life: association to infections and allergic diseases during childhood","volume":"133","author":"Janzi","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0455","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cgh.2013.02.024","article-title":"Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency","volume":"11","author":"Agarwal","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.humimm.2018.10.015_b0460","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0091-6749(79)90061-7","article-title":"Selective immunoglobulin A deficiency associated with nodular lymphoid hyperplasia","author":"Jacobson","year":"1979","journal-title":"J. Allergy Clin. Immunol. 64"},{"key":"10.1016\/j.humimm.2018.10.015_b0465","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2119\/molmed.2011.00195","article-title":"Selective IgA deficiency in autoimmune diseases","volume":"17","author":"Wang","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0470","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.169.8.4637","article-title":"MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes","volume":"169","author":"De la Concha","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0475","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/adc.63.7.771","article-title":"Clinical significance of IgG subclass deficiency","volume":"63","author":"Morgan","year":"1988","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.humimm.2018.10.015_b0480","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJM197009172831205","article-title":"Selective gamma-G globulin deficiencies in patients with recurrent pyogenic infections","volume":"283","author":"Schur","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0485","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11882-002-0067-1","article-title":"Immunoglobulin G subclass deficiency: fact or fancy?","volume":"2","author":"Buckley","year":"2002","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.humimm.2018.10.015_b0490","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CMR.00001-09","article-title":"Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections","volume":"22","author":"Fried","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.humimm.2018.10.015_b0495","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1081-1206(10)60962-3","article-title":"Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature","volume":"97","author":"Goldstein","year":"2006","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0500","doi-asserted-by":"crossref","DOI":"10.1126\/science.3931219","article-title":"Molecular defects in a human immunoglobulin kappa chain deficiency","volume":"230","author":"Stavnezer-Nordgren","year":"1985","journal-title":"Science (80\u2013)"},{"key":"10.1016\/j.humimm.2018.10.015_b0505","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejmg.2016.02.003","article-title":"Immunoglobulin K light chain deficiency: a rare, but probably underestimated, humoral immune defect","volume":"59","author":"Sala","year":"2016","journal-title":"Eur. J. Med. Genet."},{"issue":"2018","key":"10.1016\/j.humimm.2018.10.015_b0510","first-page":"129","article-title":"The IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0515","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2017.00586","article-title":"Specific antibody deficiency: controversies in diagnosis and management","volume":"8","author":"Perez","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0520","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJM198703263161306","article-title":"An immunodeficiency characterized by impaired antibody responses to polysaccharides","volume":"316","author":"Ambrosino","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0525","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2249.2006.03242.x","article-title":"The clinical syndrome of specific antibody deficiency in children","volume":"146","author":"Boyle","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0530","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/039463200802100211","article-title":"A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the italian primary immunodeficiency network","volume":"21","author":"Moschese","year":"2008","journal-title":"Int.. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.humimm.2018.10.015_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","author":"Schwab","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0540","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u201cactivated PI3K\u03b4 syndrome\u201d\u2013targeted therapy with the PI3K\u03b4 inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0545","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2015.08.036","article-title":"Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4","volume":"137","author":"Lee","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0550","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-06-2014","article-title":"Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993\u20132002","author":"Gennery","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2018.10.015_b0555","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaci.2011.07.055","article-title":"Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency","volume":"128","author":"Rizzi","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","author":"Wehr","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0565","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaci.2016.09.040","article-title":"Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome","volume":"139","author":"Nademi","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0570","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2016.01.045","article-title":"Hematopoietic stem cell transplantation for CTLA4 deficiency","volume":"138","author":"Slatter","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0575","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jaci.2017.04.023","article-title":"Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation","volume":"141","author":"Seidel","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0580","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jaci.2013.11.021","article-title":"A common single nucleotide polymorphism impairs B-cell activating factor receptor\u2019s multimerization, contributing to common variable immunodeficiency","volume":"133","author":"Pieper","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0585","doi-asserted-by":"crossref","DOI":"10.1038\/ni974","article-title":"Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination","author":"Imai","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0590","doi-asserted-by":"crossref","DOI":"10.1042\/bst0300815","article-title":"Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation","volume":"30","author":"Durandy","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.humimm.2018.10.015_b0595","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2796.2008.01971.x","article-title":"Revisiting human primary immunodeficiencies","volume":"264","author":"Casanova","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0600","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","article-title":"Host susceptibility to non-tuberculous mycobacterial infections","volume":"15","author":"Wu","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.humimm.2018.10.015_b0605","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2018.10.015_b0610","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2018.10.015_b0615","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clim.2015.05.020","article-title":"Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders","volume":"160","author":"van Schouwenburg","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.10.015_b0620","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918302544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918302544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:51:53Z","timestamp":1759319513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918302544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0198885918302544"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.10.015","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary B-cell immunodeficiencies","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}